image_alt_text
3

Christopher Loose, Ph.D.

AIMBE College of Fellows Class of 2022
For outstanding contributions to the field of engineering by translating groundbreaking technologies in areas of great unmet clinical need.

Dr. Christopher Loose Elected to the 2022 Class of the AIMBE College of Fellows

Via AIMBE | February 18, 2022

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Christopher Loose, Ph.D., Co-Founder and Chief Scientific Officer, Frequency Therapeutics to its College of Fellows. Dr. Loose was nominated, reviewed, and elected by peers and members of the AIMBE College of Fellows for outstanding contributions to the field of engineering by translating groundbreaking technologies in areas of great unmet clinical need.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation, and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences… Continue reading.

...